ONE-WAYOngoing theme · still written in the latest filings
Indication expansion and Phase III investigator-initiated clinical trial plan for recurrent malignant glioma
An individual development theme aimed at advancing consultations with PMDA and planning additional studies, followed by a partial-change application and the launch of a Phase III investigator-initiated clinical trial for recurrent malignant glioma.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.